H.J. Hoekstra

2.6k total citations · 1 hit paper
26 papers, 1.8k citations indexed

About

H.J. Hoekstra is a scholar working on Oncology, Surgery and Cancer Research. According to data from OpenAlex, H.J. Hoekstra has authored 26 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 9 papers in Surgery and 7 papers in Cancer Research. Recurrent topics in H.J. Hoekstra's work include Cutaneous Melanoma Detection and Management (10 papers), Breast Cancer Treatment Studies (4 papers) and Optical Coherence Tomography Applications (3 papers). H.J. Hoekstra is often cited by papers focused on Cutaneous Melanoma Detection and Management (10 papers), Breast Cancer Treatment Studies (4 papers) and Optical Coherence Tomography Applications (3 papers). H.J. Hoekstra collaborates with scholars based in Netherlands, United States and Germany. H.J. Hoekstra's co-authors include Robert M. Elashoff, Constantine P. Karakousis, Daniel F. Roses, Donald L. Morton, Brendon J. Coventry, Mark B. Faries, Nicola Mozzillo, John F. Thompson, Omgo E. Nieweg and Mohammed Kashani–Sabet and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and International Journal of Cancer.

In The Last Decade

H.J. Hoekstra

25 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma

2014 943 citations Donald L. Morton, John F. Thompson et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by H.J. Hoekstra

Since Specialization

Citations

This map shows the geographic impact of H.J. Hoekstra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.J. Hoekstra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.J. Hoekstra more than expected).

Fields of papers citing papers by H.J. Hoekstra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.J. Hoekstra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.J. Hoekstra. The network helps show where H.J. Hoekstra may publish in the future.

Co-authorship network of co-authors of H.J. Hoekstra

This figure shows the co-authorship network connecting the top 25 collaborators of H.J. Hoekstra. A scholar is included among the top collaborators of H.J. Hoekstra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.J. Hoekstra. H.J. Hoekstra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tumor Mitotic Rate Added to the Equation: Melanoma Prognostic Factors Changed? 2015 ·Annals of Surgical Oncology ·(unknown), Esther Bastiaannet, Sarah Sloot, Albert J.H. Suurmeijer, H.J. Hoekstra	26
2	Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma breakdown → 2014 ·New England Journal of Medicine ·Donald L. Morton, John F. Thompson, Amalia Cochran, Nicola Mozzillo, Omgo E. Nieweg, Daniel F. Roses, H.J. Hoekstra, Constantine P. Karakousis, Christopher A. Puleo, Brendon J. Coventry, Mohammed Kashani–Sabet, B. Mark Smithers, Eberhard Paul, William Kraybill, J. Gregory McKinnon, Hong Wang, Robert M. Elashoff, Mark B. Faries	943
3	Long-term follow-up reveals that ulceration and sentinel lymph node status are the strongest predictors for survival in patients with primary cutaneous melanoma 2011 ·European Journal of Surgical Oncology ·M. de Vries, (unknown), Esther Bastiaannet, John Th. M. Plukker, Adrienne H. Brouwers, Robert J. van Ginkel, Albert J.H. Suurmeijer, H.J. Hoekstra	26
4	VEGF-SPECT with In-111-bevacizumab in stage III/IV melanoma patients 2010 ·European Journal of Nuclear Medicine and Molecular Imaging ·Marjolijn N. Lub–de Hooge, (unknown), Adrienne H. Brouwers, Johan R. de Jong, Harry Hollema, Rudi Dierckx, Nanno H. Mulder, Elisabeth G.E. de Vries, H.J. Hoekstra, Geke A.P. Hospers	1
5	The Impact on Morbidity and Length of Stay of Early Versus Delayed Complete Lymphadenectomy in Melanoma: Results of the Multicenter Selective Lymphadenectomy Trial (I) 2010 ·Annals of Surgical Oncology ·(unknown), Mark B. Faries, John F. Thompson, Alistair J. Cochran, Robert M. Elashoff, Edwin C. Glass, Nicola Mozzillo, Omgo E. Nieweg, Daniel F. Roses, H.J. Hoekstra, Constantine P. Karakousis, Douglas S. Reintgen, Brendon J. Coventry, (unknown), Donald L. Morton	130
6	Towards clinical VEGF imaging using the anti-VEGF antibody bevacizumab and Fab-fragment ranibizumab 2008 ·Journal of Clinical Oncology ·(unknown), Marjolijn N. Lub–de Hooge, Geke A.P. Hospers, Adrienne H. Brouwers, H.J. Hoekstra, (unknown), Nanno H. Mulder, (unknown), Elisabeth G.E. de Vries	6
7	Treatment related morbidity in breast cancer patients 2007 ·University of Twente Research Information ·Johan S. Rietman, Jan H. B. Geertzen, Pieter U. Dijkstra, H.J. Hoekstra	1
8	Response: The value of sentinel lymph node biopsy in the management of head and neck melanoma 2007 ·Journal of Surgical Oncology ·M. H. Edwina Doting, M. de Vries, J. T. Plukker, P. L. Jager, Wendy J. Post, Albert J.H. Suurmeijer, H.J. Hoekstra	1
9	Positron emission tomography in patients with breast cancer using 18F-3′-deoxy-3′-fluoro-l-thymidine (18F-FLT)—a pilot study 2005 ·European Journal of Surgical Oncology ·(unknown), P. H. Elsinga, Jakob de Vries, (unknown), P. L. Jager, H.J. Hoekstra, Albert J.H. Suurmeijer	49
10	Treatment-Related Upper Limb Morbidity 1 Year after Sentinel Lymph Node Biopsy or Axillary Lymph Node Dissection for Stage I or II Breast Cancer 2004 ·Annals of Surgical Oncology ·Johan S. Rietman, Pieter U. Dijkstra, Jan H. B. Geertzen, (unknown), Jakob de Vries, Wil V. Dolsma, Johan W. Groothoff, W. H. Eisma, H.J. Hoekstra	97
11	The management of clear cell sarcoma 2003 ·European Journal of Surgical Oncology ·(unknown), H.J. Hoekstra, R. P. H. Veth, Th. Wobbes	35
12	Detection of micrometastatic breast cancer by means of real time quantitative RT‐PCR and immunostaining in perioperative blood samples and sentinel nodes 2003 ·International Journal of Cancer ·Carolien P. Schröder, Marcel H.J. Ruiters, Steven de Jong, A.T.M.G. Tiebosch, Jelle Wesseling, (unknown), Jaap de Vries, H.J. Hoekstra, Lou F. M. H. de Leij, Elisabeth G.E. de Vries	38
13	Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: a systematic review 2003 ·European Journal of Surgical Oncology ·Johan S. Rietman, Pieter U. Dijkstra, H.J. Hoekstra, W. H. Eisma, (unknown), Johan W. Groothoff, Jan H. B. Geertzen	210
14	Is sentinel node biopsy beneficial in melanoma patients? A report on 200 patients with cutaneous melanoma 2002 ·European Journal of Surgical Oncology ·M. H. Edwina Doting, H.J. Hoekstra, John Th. M. Plukker, D.A. Piers, P. L. Jager, A.T.M.G. Tiebosch, A Vermey, H. Schraffordt Koops	63
15	Sentinel node biopsy as a surgical staging method for solid cancers 1999 ·Radiotherapy and Oncology ·Heimen Schraffordt Koops, M. H. Edwina Doting, Jakob de Vries, (unknown), John Th. M. Plukker, H.J. Hoekstra, D.A. Piers	46
16	Cytogenetic analysis of a case of myxoid liposarcoma with cartilaginous differentiation 1996 ·Cancer Genetics and Cytogenetics ·Trijnie Dijkhuizen, Willemina M. Molenaar, H.J. Hoekstra, Janneke Wiersema, Anke van den Berg	14
17	Fantasies and facts of the testes 1996 ·British Journal of Urology ·J.P. van Basten, Grieteke Jonker-Pool, Mels F. van Driel, D.Th. Sleijfer, H.B.M. van de Wiel, H.J.A. Mensink, Heimen Schraffordt Koops, H.J. Hoekstra	24
18	Intraoperative Strahlentherapie inklusive Afterloadingverfahren in der gastrointestinalen Chirurgie 1995 ·F. W. Schildberg, (unknown), Felipe A. Calvo, (unknown), (unknown), H.J. Hoekstra, Martin K. Walz, Ralf Wilkowski	0
19	Local tumor control by intra-operative radiotherapy (IORT): a pilot experience. 1991 ·PubMed ·H.J. Hoekstra, D. M. Mehta, (unknown), (unknown), J Oldhoff	4
20	Cecal carcinoma: A different colon malignancy? 1990 ·Journal of Surgical Oncology ·Luke P. H. Leenen, Theo Wobbes, H.J. Hoekstra, Chris van der Werken	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact